Shanghai Sigma-Audley New Material Technology: difference between revisions
Diff·revision 27 → 28·06:52, 15 Mar 2025
Difference between revision 27 and revision 28 of Shanghai Sigma-Audley New Material Technology. 7 lines changed; the page grew by 144 bytes.
| Revision 27 — 12:26, 7 Mar 2025 Peptide_Pete (talk) ce, tighten prose 6,913 bytes +318 | Revision 28 — 06:52, 15 Mar 2025 BlankVialBo (talk) add DOI 7,057 bytes +144 | ||
|---|---|---|---|
| 58 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 58 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 59 | 59 | ||
| + | 60 | == See also == | |
| + | 61 | * [[Certificate of analysis]] | |
| + | 62 | * [[Third-party testing]] | |
| + | 63 | * [[Area percent purity]] | |
| + | 64 | * [[Peptide content]] | |
| + | 65 | * [[Research use only]] | |
| + | 66 | ||
| 60 | {{DEFAULTSORT:Shanghai Sigma-Audley New Material Technology}} | 67 | {{DEFAULTSORT:Shanghai Sigma-Audley New Material Technology}} |
| 61 | [[Category:Peptide suppliers]] | 68 | [[Category:Peptide suppliers]] |